426 related articles for article (PubMed ID: 32477261)
21. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
22. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
23. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.
Borén J; Watts GF; Adiels M; Söderlund S; Chan DC; Hakkarainen A; Lundbom N; Matikainen N; Kahri J; Vergès B; Barrett PH; Taskinen MR
Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2218-24. PubMed ID: 26315407
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
Dergunov AD
Biochemistry (Mosc); 2004 Jul; 69(7):720-37. PubMed ID: 15310270
[TBL] [Abstract][Full Text] [Related]
25. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
[TBL] [Abstract][Full Text] [Related]
26. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
Dunbar RL; Nicholls SJ; Maki KC; Roth EM; Orloff DG; Curcio D; Johnson J; Kling D; Davidson MH
Lipids Health Dis; 2015 Sep; 14():98. PubMed ID: 26328624
[TBL] [Abstract][Full Text] [Related]
27. Serum triglycerides and risk of cardiovascular disease.
Boullart AC; de Graaf J; Stalenhoef AF
Biochim Biophys Acta; 2012 May; 1821(5):867-75. PubMed ID: 22015388
[TBL] [Abstract][Full Text] [Related]
28. Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein.
Sniderman AD; Tremblay A; De Graaf J; Couture P
J Clin Lipidol; 2012; 6(5):427-33. PubMed ID: 23009778
[TBL] [Abstract][Full Text] [Related]
29. Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins.
Cortner JA; Le NA; Coates PM; Bennett MJ; Cryer DR
Eur J Clin Invest; 1992 Mar; 22(3):158-65. PubMed ID: 1582440
[TBL] [Abstract][Full Text] [Related]
30. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiology of hypertriglyceridemia.
Hassing HC; Surendran RP; Mooij HL; Stroes ES; Nieuwdorp M; Dallinga-Thie GM
Biochim Biophys Acta; 2012 May; 1821(5):826-32. PubMed ID: 22179026
[TBL] [Abstract][Full Text] [Related]
32. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976
[TBL] [Abstract][Full Text] [Related]
33. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
Björkegren J; Karpe F; Milne RW; Hamsten A
J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
[TBL] [Abstract][Full Text] [Related]
34. Postprandial remnant lipoproteins as targets for the prevention of atherosclerosis.
Nakajima K; Tanaka A
Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):108-117. PubMed ID: 29493553
[TBL] [Abstract][Full Text] [Related]
35. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
[No Abstract] [Full Text] [Related]
36. Hypertriglyceridemia in nephrotic rats is due to a clearance defect of plasma triglyceride: overproduction of triglyceride-rich lipoprotein is not an obligatory factor.
Yoshino G; Hirano T; Nagata K; Maeda E; Naka Y; Murata Y; Kazumi T; Kasuga M
J Lipid Res; 1993 Jun; 34(6):875-84. PubMed ID: 8354953
[TBL] [Abstract][Full Text] [Related]
37. [Features of hypertriglyceridemia in chronic kidney disease(CKD)].
Saito T
Nihon Rinsho; 2013 Sep; 71(9):1618-22. PubMed ID: 24205724
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of hypertriglyceridemia].
Imano H; Iso H
Nihon Rinsho; 2013 Sep; 71(9):1528-35. PubMed ID: 24205710
[TBL] [Abstract][Full Text] [Related]
40. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
Gotto AM
Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
